Overview
Luyun Peng practices practicing medicine in Chengdu, China.
Their clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Prothrombin Deficiency, Leukemia, and Methemoglobinemia.
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Luyun Peng
Is Luyun Peng a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?
MediFind is an objective health platform that identifies experts based on real-world data. Luyun Peng is classified as an Experienced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Luyun Peng participate in research or clinical trials?
Yes. Luyun Peng has published 16 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Luyun Peng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- LeukemiaPeng isExperienced. Learn about Leukemia.
- MethemoglobinemiaPeng isExperienced. Learn about Methemoglobinemia.
- Prothrombin DeficiencyPeng isExperienced. Learn about Prothrombin Deficiency.